Best Life Sciences Companies in Gothenburg, Sweden
The 79 best Life Sciences companies in Gothenburg, Sweden in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Albireo Pharma.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Gothenburg
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Albireo Pharma Developer of novel bile acid modulators to treat gastrointestinal diseases | $40M | 165 mo ago | 3 | 2008 | — | — | — |
| 2 | Cinclus Pharma Developer of small molecules for the treatment of gastric acid-related diseases | $26M | 50 mo ago | 11 | 2014 | Marek Poszepczynski Co-Founder | 42 patents Linaprazan glurate salt polymorphs and formulations for GERD acid‑suppression therapy | — |
| 3 | OnDosis Developer of an oral drug delivery system | $14M | 60 mo ago | 32 | 2017 | Martin Olovsson CEO and co-founder | 45 patents Automated solid-dose drug pellet dispensing and delivery systems | — |
| 4 | Oblique Therapeutics Developer of antibodies and small molecules for the treatment of advanced and metastatic cancer | $12M | 67 mo ago | 23 | 2015 | — | 126 patents TRPV1-targeted antibodies/epitope selection and sulfonyl‑pyridine oncology therapeutics | — |
| 5 | Neoventa Fetal monitoring solutions and services that improve obstetric care | $8M | 239 mo ago | 12 | 1997 | — | — | 2 job openings |
| 6 | Denator Technology for stabilization of biological tissues and samples | $8M | 131 mo ago | 7 | 2004 | Karl Sköld Co-Founder & Board Member | 20 patents Preserving and preparing biological samples for analytical testing and diagnostics | — |
| 7 | VERIGRAFT Developer of personalized tissue-engineered transplants | $6M | 16 mo ago | 12 | 2004 | Petter Bjorquist CEO | 46 patents Personalized bioengineered nerve and blood vessel grafts for regenerative surgery | 2 partnerships |
| 8 | Melt&Marble Platform offering plant-based meat alternative products | $6M | 6 mo ago | 20 | 2014 | Florian David Co-Founder | 22 patents Patents concentrated in chemistry & materials | — |
| 9 | Captario Design and decision support solutions for pharma R&D | $6M | 95 mo ago | 45 | 2012 | Ingela Nylander Co-founder | — | — |
| 10 | Promimic Biomaterial coating for artificial implants | $5M | 117 mo ago | 16 | 2004 | — | 70 patents Bioactive bone scaffolds and zirconium/titanium phosphate implant surface coatings | — |
| 11 | Texray Manufacturer of radiation protection textile for clinical practitioners | $4M | 31 mo ago | 8 | 2020 | — | 14 patents Medical radiation shielding devices and protective garments for patient protection | — |
| 12 | Amferia Developer of an anti-infective technology | $3M | 6 mo ago | 7 | 2018 | Anand Rajasekharan Co-Founder & CEO | 37 patents Advanced wound-care devices, bioactive dressings, and endotoxin‑neutralizing biomaterials | — |
| 13 | Integrative Research Laboratories Using systems pharmacology to develop small molecule therapeutics for neurodegenerative diseases | $3M | 66 mo ago | 33 | 2013 | — | — | — |
| 14 | TATAA Biocenter CRO for molecular analysis offering scientific research, clinical trials and drug development | $3M | 30 mo ago | 66 | 2001 | — | 12 patents Small RNA library preparation and mutant nucleic acid detection assay technologies | 1 job opening |
| 15 | Emeriti Pharma Company developing novel candidates for treating dermatological disorders | $2M | 113 mo ago | — | 2014 | David Gustafsson CEO | 11 patents Piperidine‑isoxazolone compounds for treating skin disorders (topical dermatology therapeutics) | — |
| 16 | Metabogen Metagenomic services for the pharmaceutical industry. | $1M | 103 mo ago | 6 | 2011 | — | 79 patents Microbiome‑based probiotic therapies for diabetes, bowel and liver disease treatment | — |
| 17 | Lucero Provider of a lab-on-chip microfluidics technology platform by combining laser optics and AI | $1M | 41 mo ago | 8 | 2020 | Christopher Jacklin Co-Founder | — | — |
| 18 | Nanolyze Developer of nanoparticles-based solutions for drug delivery | $1M | 60 mo ago | 5 | 2020 | — | 6 patents Photonic waveguide designs and hydrodynamic nanoparticle sizing (dynamic light scattering) technologies. | — |
| 19 | Stayble Therapeutics Developing lactic acid based intradiscal injectible formulation for chronic low back pain (cLBP) | $1M | 87 mo ago | 3 | 2012 | Andreas Gerward CEO | 64 patents Injectable lactic‑acid compositions for treating intervertebral disc degeneration and herniation | — |
| 20 | Medfield Diagnostics Systems for pre-hospitalization diagnostics of brain injuries | $641K | 81 mo ago | 8 | 2003 | — | 22 patents Non‑invasive RF/microwave scattering diagnostics for internal object detection and tissue characterization. | — |
| 21 | LayerLogic Developer of biosensing technology for rapid bacteria, virus, fungi, detection | $541K | 12 mo ago | — | 2023 | Avgust Yurgens Co-Founder | 2 patents Scalable manufacturing of graphene materials for large‑area electronic and composite applications | — |
| 22 | Artimplant AB Implants for the treatment of osteoarthritis and the reinforcement of weakened soft tissue | $540K | 171 mo ago | — | 1990 | Kjell Thornbring CEO and President | 32 patents Biodegradable fiber-based surgical implants for soft tissue and osteochondral reconstruction | — |
| 23 | Monivent Non-invasive monitoring device for manual ventilation in babies | $424K | 127 mo ago | 8 | 2013 | Pontus Johansson Co Founder | 19 patents Advanced respiratory devices with laminar flow channels and pressure‑flow control mechanisms. | — |
| 24 | Novahep AB Developing stem cell technology for generating human tissues | $291K | 115 mo ago | — | 2005 | Jan Holgersson Founder and Board Member | 42 patents Allogeneic bioengineered vascular grafts and bioprinted organ/tissue manufacturing | — |
| 25 | Kromnigon Manufacturer of multicoloured stains for microscopic image highlighting | $290K | 58 mo ago | 8 | 2015 | Ulf Yrlid Co-Founder | 25 patents Fluorescence microscopy systems and immunolabeling sample preparation technologies. | 2 launchs |
| 26 | Nanoxis Technology for the immobilization and study of proteoliposomes | $216K | 273 mo ago | — | 2002 | Roger Karlsson Co-Founder | 28 patents Plasma membrane vesicle platforms for drug screening and biosensor device development | — |
| 27 | Cereduce Metabolic engineering of yeast for low alcohol fermentation | $204K | 169 mo ago | 2 | 2010 | Fredrik Weschke CEO | 5 patents Engineered yeast with chimeric glucose transporters for enhanced sugar uptake in bioprocessing | — |
| 28 | Alzinova Early-stage, public, Swedish Biotech company developing oligomer-directed vaccine and mAbs for Alzheimers'… | $164K | 105 mo ago | 4 | 2011 | Anders Sandberg Co-Founder | 24 patents Humanized antibodies targeting amyloid‑beta 42 for Alzheimer's disease treatment | 1 partnership |
| 29 | Micropos Electromagnetic positioning system for Prostrate tracking during radiotherapy | $135K | 157 mo ago | 6 | 2003 | — | — | — |
| 30 | Toleranzia Developer of drugs for treating autoimmune orphan diseases & rare diseases | $112K | 84 mo ago | 16 | 2011 | Charlotte Fribert CEO | 15 patents Therapeutic fusion proteins and peptide combos for autoimmune disease, especially myasthenia gravis | — |
| 31 | 1928 Diagnostics Provider of diagnostic software-as-a-service for antibiotic-resistant bacterial infections | $106K | 126 mo ago | 17 | 2014 | Kristina Lagerstedt Co-Founder & CEO | — | — |
Top 12 Life Sciences companies in Gothenburg
#1
Series A · Gothenburg, Vastra Gotaland County · founded 2014 · 20 employees$6.2Mraised▾
Platform offering plant-based meat alternative products. The company uses precision fermentation to create animal fats. It uses synthetic biology and metabolic engineering allowing to build of proprietary yeast strains. Its microbial metabolism can dictate the structure and properties of the fats that the microbes are producing, allowing to mimic the fat structure.
- Dec 2025Series A$8.5M
- Jul 2024Grant (prize money)$3M
- May 2022Seed$5.3M
- Aug 2021Seed$876.3K
#2
Series B · Gothenburg, Vastra Gotaland County · founded 2018 · 7 employees$3.5Mraised▾
Amferia is developing an anti-infective technology. The company has developed its proprietary patented technology which consists of anti-bacterial polymers that can kill bacteria including antibiotic-resistant bacteria. The material is selective and targets only bacteria and is non-toxic to human cells.
- Dec 2025Series B$4.1M
- Sep 2024Series A$1.3M
- Jan 2023Series A$1.5M
- Feb 2020Grant (prize money)$55K
#3
Funding Raised · Gothenburg, Vastra Gotaland County · founded 2004 · 12 employees$6.2Mraised▾
VERIGRAFT is developing personalized tissue-engineered transplants. The company is using is regenerative medicine technology to develop biological transplants that are free from immunosuppression and infections. The company has completed preclinical tests for personalized tissue-engineered veins (P-TEV). The product is being tested for chronic venous insufficiency.
- Feb 2025Grant (prize money)$1.3M
- Aug 2019Grant (prize money)$2.4M
- Sep 2017Grant (prize money)$2.6M
- Grant (prize money)—
#4
Seed · Gothenburg, Vastra Gotaland · founded 2023$541.3Kraised▾
Developer of biosensing technology for rapid bacteria, virus, fungi, detection. The technology offers portable bacteria detection and quantification. The company's method can detect any bacteria, virus, fungi, or molecule.
- 2025Seed$541.3K
#5
Public · Gothenburg, Vastra Gotaland County · founded 2011 · 68 employees$56.2Kraised▾
Intellego Technologies is developing dosimeter technology. Their technology is patented photochromic ink which changes colour when it is exposed to a certain amount of radiation or substances. Currently they are focussing on products in consumer, hospital and construction industry. They have applications in many other areas aslo.
- Nov 2025Post IPO$22M
- Jul 2017Seed$56.2K
#6
Public · Gothenburg, Vastra Gotaland County · founded 2014 · 11 employees$25.7Mraised▾
Developer of small molecules for the treatment of gastric acid-related diseases. The lead candidate of the company is Linaprazan glurate a potassium-competitive acid blocker (P-CAB) and a prodrug of linaprazan for the treatment of erosive Gastroesophageal reflux disease (eGERD).
- Apr 2022Series B—
- Mar 2020Series B$25.7M
#7
Funding Raised · Gothenburg, Vastra Gotaland County · founded 2001 · 66 employees$2.9Mraised▾
CRO for molecular analysis offering scientific research, clinical trials and drug development. It offers a wide range of bioanalytical services to help support drug development in the pharmaceutical industry. Its services include PCR services, NGS, and protemics.
- Dec 2023Grant (prize money)$27.4K
- Jan 2021Grant (prize money)$601.4K
- Apr 2020Grant (prize money)$288.6K
- Jan 2020Grant (prize money)$1.2M
#8
Series A · Gothenburg, Vastra Gotaland County · founded 2020 · 8 employees$4.3Mraised▾
Manufacturer of radiation protection textile for clinical practitioners
- Nov 2023Series A$4.3M
- Jul 2021Seed—
#9
Series B · Gothenburg, Vastra Gotaland County · founded 2017 · 32 employees$14.5Mraised▾
Developer of an oral drug delivery system. The product developed by the company known as OnDosis 01 helps in individualized dosing of oral medicines even in micro-units volume. This device can be used by patients with attention-deficit/hyperactivity disorder (ADHD) who are not able to continuously take medicine at the right time.
- May 2021Series B$11.1M
- Sep 2020Series A$3.4M
- Sep 2019Grant (prize money)$54.7K
- Apr 2019Grant (prize money)$56K
#10
Acquired · Gothenburg, Vastra Gotaland County · founded 2008 · 3 employees$40Mraised▾
Developer of novel bile acid modulators to treat gastrointestinal diseases. It offers bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal disorders. Its clinical pipeline includes Elobixibat and Bylvay potent and selective ileal bile acid transporter, and A4250 a IBAT inhibitor for cholestatic liver disease.
- Feb 2008Series A$40M
#11
Series A · Gothenburg, Vastra Gotaland County · founded 2015 · 23 employees$11.7Mraised▾
Oblique Therapeutics is a developer of antibodies and small molecules for the treatment of advanced and metastatic cancer. The company's drugs are based on two platforms that are proprietary antibody platform for functional antibodies, and metabolic cytotoxics with immunomodulatory potential. It's lead functional antibodies are against TRPV1 and TRPV2 for the treatment of inflammatory/idiopathic pain and metastatic cancer.
- Nov 2020Series A$11.4M
- Dec 2015Seed$296.9K
#12
Public · Gothenburg, Vastra Gotaland County · founded 2013 · 33 employees$3.4Mraised▾
Integrative Research Laboratories Sweden AB (IRL) is a Swedish privately held drug discovery and development company providing novel treatments in the field of primary neurodegenerative disorders. IRL is pursuing small molecule programmes targeting core disabilities in dementias, attention disorders and Parkinson’s disease using its unique systems pharmacology discovery approach, the Integrative Screening Process (ISP), to find new treatment solutions. IRL utilizes an in vivo systems pharmacology approach based on phenotypic screening, systematically implemented and seamlessly integrated throughout the drug discovery process in a process referred to as the Integrative Screening Process (ISP). Phenotypic screening has proven more successful than target based screening in generating first-in-class drugs within the CNS area (as published in Nature Reviews Drug Discovery, 2011, Jun 24). ISP is based on studies of physiological and pathophysiological mechanisms at the system level in the living brain and the effects of drugs and drug candidates on these mechanisms at the integrated level. A screening system is built on in vivo systems responses, combined with strong medicinal chemistry
- Dec 2020Post IPO$15.7M
- Feb 2019Grant (prize money)$56.9K
- Nov 2018Grant (prize money)$57K
- May 2018Post IPO$16M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Gothenburg researches in biotechnology
- University of Gothenburg28
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.